The Era of immunotherapeutics: Overcoming the challenges to fulfill the potential

By boosting anti-cancer response using a patient’s own immune system, immunotherapeutics are showing incredible promise in offering more effective treatments with fewer side effects for cancer patients.

The Era of immunotherapeutics: Overcoming the challenges to fulfill the potential

There is also potential to help in other areas, such as infectious and neurodegenerative diseases. But there are still obstacles to the further development and adoption of immune therapies.

In this white paper you will learn how rapidly expanding immune biology knowledge drives innovation and challenges for drug developers:

  • The unique challenges of drug target and candidate selection
  • The expanding selection of immune therapies showcases innovation in delivering cytotoxic drugs to the specific tumor and include, Anticancer monoclonal antibodies (mAbs), immune checkpoint inhibitors (ICIs) and other types of immunotherapeutics
  • Unique adverse effects of different immune therapies

Read the white paper.

To access the complimentary white paper 'The Era of Immunotherapeutics: Overcoming the Challenges to Fulfill the Potential', please fill in the form below.

Elsevier's R&D Solutions for Drug Discovery & Development


Drive successful early drug discovery by providing chemists the shortest path to relevant literature, patent information, valid compound properties, and experimental procedures.

Learn more about Reaxys
Contact a Reaxys expert

Reaxys Medicinal Chemistry

Achieve more efficient hit identification and lead optimization by providing chemists the shortest path to normalized compound–target affinity data and comprehensive pharmacokinetic, efficacy, toxicity, safety and metabolic profiles.
Learn more about Reaxys Medicinal Chemistry
Contact a Reaxys Medicinal Chemistry expert


Make more informed drug development decisions on safety and efficacy, risk assessments and mitigation, and study designs by providing researchers with searchable FDA/EMA drug approval documents and comparative drug safety data.
Learn more about PharmaPendium
Contact a PharmaPendium expert


Uncover drug-disease relationships and drug-drug interactions by increasing the discovery of biomedical evidence and providing comprehensive relevant, up-to-date biomedical information.

Learn more about Embase
Contact a Embase expert

Pathway Studio

Streamline target and biomarker identification and drug repurposing by providing biological researchers with greater insight into the mechanisms of disease and facilitating the interpretation of experimental data.
Learn more about Pathway Studio
Contact a Pathway Studio expert

Professional Services

Drive innovative pharmaceutical research by resolving challenges with data quality and integration and making data easier for researchers to compare, analyze, interpret and share.

Learn more about Professional Services
Contact a Professional Services expert


Help researchers understand the entire breadth of research surrounding a disease by helping them more effectively and efficiently search authoritative, full-text scientific, technical and health content.

Learn more about ScienceDirect
Contact a ScienceDirect expert


Detect trends, find partnerships and identify experts to stay on the cutting edge of research through the world’s largest abstract and citation database of peer-reviewed literature, including tools to track, analyze and visualize research.
Learn more about Scopus
Contact a Scopus expert